ArticleMolecular and cellular biology2010

Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.

David R Croucher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.